EDWARDS PASCAL PRECISION
Report
- Report Number
- 2015691-2025-02871
- Event Type
- Injury
- Date Received
- April 14, 2025
- Date of Event
- February 21, 2025
- Report Date
- May 23, 2025
- Manufacturer
- EDWARDS LIFESCIENCES
- Product Code
- NKM
- PMA / PMN Number
- P220003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
LITERATURE CITATION: LAI LKL, ALRAYES H, FRAM G, LEE JC, ZWEIG B, O'NEILL BP, FRISOLI TM, GONZALEZ PE, O'NEILL WW, VILLABLANCA PA. IATROGENIC ATRIAL SEPTAL DEFECT CLOSURE WITH PASCAL GUIDE SYSTEM POST-MITRAL VALVE TRANSCATHETER EDGE-TO-EDGE REPAIR. J INVASIVE CARDIOL. 2025 FEB 21. DOI: 10.25270/JIC/25.00031. EPUB AHEAD OF PRINT. PMID: 39993275. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.
ADDITIONAL H6 TYPE OF INVESTIGATION CODE: 'ANALYSIS OF IMAGES' AND 'LABELLING REVIEW'. THE COMPLAINT FOR DIFFICULT/UNABLE TO INSERT DEVICE INTO TRANSSEPTAL PUNCTURE LOCATION WAS UNABLE TO BE CONFIRMED. NO DEVICE WAS RETURNED FOR EVALUATION. AN IMAGE OF THE ATRIAL SEPTAL DEFECT COULD BE FOUND IN THE JOURNAL ARTICLE ALLEGING THE EVENT. OTHER IMAGES INCLUDED IN THE ARTICLE ARE RELATED TO THE STEPS TAKEN TO REPAIR THE SEPTAL DEFECTS RATHER THAN THE PASCAL PROCEDURE. IT IS UNCLEAR IF THE ATRIAL SEPTAL DEFECT WAS A RESULT OF INSERTING THE DEVICE INTO THE TRANSSEPTAL PUNCTURE LOCATION OR IF THERE ARE OTHER POTENTIAL PROCEDURAL STEPS IT COULD HAVE OCCURRED AT AS THERE ARE FEW DETAILS ON THE PASCAL PROCEDURE PROVIDED IN THE ARTICLE. THE ATRIAL SEPTAL DEFECT WAS NOTED TO BE FOUND POST-PROCEDURE AND THERE WAS NO ALLEGATION OF DIFFICULTIES INSERTING THE DEVICE INTO THE TRANSSEPTAL PUNCTURE LOCATION. NO DEVICE LOT INFORMATION WAS PROVIDED THEREFORE, A DEVICE HISTORY RECORD REVIEW AND A LOT HISTORY REVIEW COULD NOT BE COMPLETED. PER THE INSTRUCTIONS FOR USE (IFU), ATRIAL / SEPTAL WALL DAMAGE AND PERICARDIAL EFFUSION IS A KNOWN POTENTIAL ADVERSE EVENT WHICH HAVE BEEN IDENTIFIED AS A POSSIBLE COMPLICATION OF MITRAL AND TRICUSPID VALVE REPAIR, INCLUDING THE PASCAL IMPLANT PROCEDURE. THERE ARE MULTIPLE PATIENT AND PROCEDURAL FACTORS THAT ALONE OR IN COMBINATION CAN CAUSE OR CONTRIBUTE TO SUCH INJURY. POOR TRANSEPTAL PUNCTURE (TSP) LOCATION AND OR ANATOMICAL CHALLENGES CAN BE TWO COMMON FACTORS THAT CAN CAUSE THESE TYPES OF EVENTS. THE PASCAL TRAINING MANUALS INSTRUCT THE OPERATOR ON PROPER POSITIONING AND DEPLOYMENT OF THE TSP. PHYSICIANS ARE TRAINED BY EDWARDS TEAM MEMBERS BEFORE THEY ARE QUALIFIED TO USE THE PASCAL SYSTEM. TRAINING INCLUDES PATIENT SCREENING (TO ENSURE ANATOMY IS SUITABLE FOR THE DEVICE), DEVICE PREPARATION, APPROACH, DEPLOYMENT, IMAGING, PROCEDURE-SPECIFIC TRAINING MANUALS AND PROCTORED PROCEDURES. OPERATORS ARE ALSO INSTRUCTED TO USE FLUOROSCOPY IN CONJUNCTION WITH ECHOCARDIOGRAPHY FOR OPTIMAL VISUALIZATION DURING POSITIONING AND DEPLOYMENT OF THE DEVICE. IN THIS CASE, THERE IS VERY LITTLE INFORMATION ON THE PASCAL PROCEDURE THEREFORE, A ROOT CAUSE COULD NOT BE DETERMINED.
EDWARDS RECEIVED NOTIFICATION OF A PASCAL IN MITRAL POSITION WHERE THE PATIENT SUCCESSFULLY UNDERWENT INTRACARDIAC ECHOCARDIOGRAPHY-GUIDED MITRAL VALVE TEER USING 1 PASCAL P10 DEVICE AND 2 PASCAL ACE DEVICES. POST-PROCEDURE, A 1.2-CM IASD WITH A BIDIRECTIONAL SHUNT AND OXYGEN DESATURATION WAS IDENTIFIED. URGENT CLOSURE WAS PERFORMED USING A 22-MM AMPLATZ ASD OCCLUDER (ABBOTT). THE PASCAL GUIDE SHEATH WAS RE-CROSSED TO THE LEFT ATRIUM USING A DILATOR OVER AN AMPLATZ SUPER STIFF WIRE (BOSTON SCIENTIFIC). AFTER REMOVING THE DILATOR AND WIRE, A 9-FR FEMORAL SHEATH WAS ADVANCED INTO THE GUIDE SHEATH TO PASS ITS SEALING VALVE. THE 22 MM AMPLATZ ASD DEVICE WAS THEN LOADED INTO THE 9 FR SHEATH AND ADVANCED. THE LOADER WAS SUBSEQUENTLY REMOVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1092532 | EDWARDS PASCAL PRECISION | MITRAL VALVE REPAIR DEVICES | NKM | EDWARDS LIFESCIENCES | 20000GS |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 87 YR | Female | Required Intervention |